This Article Full Text Full Text (PDF) Other Versions of this Article: CVI.00288-07v1 14/12/1555    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Putkuri, N. Articles by Vapalahti, O. Search for Related Content PubMed PubMed Citation Articles by Putkuri, N. Articles by Vapalahti, O.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, December 2007, p. 1555-1562, Vol. 14, No. 12
1071-412X/07/$08.00+0     doi:10.1128/CVI.00288-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Prevalence and Protein Specificity of Human Antibodies to Inkoo Virus Infection

Department of Virology, Haartman Institute, University of Helsinki, Helsinki, Finland,¹ Department of Virology, Helsinki University Central Hospital Laboratory, Helsinki, Finland,² Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland³

Received 4 July 2007/ Returned for modification 24 August 2007/ Accepted 11 October 2007

Inkoo virus (INKV), a member of the California serogroup orthobunyaviruses, is circulating widely in northern Europe. Although the virus was discovered over 40 years ago, the disease associations and immune responses in human infection are poorly characterized. We first developed an immunofluorescence assay (IFA) for the detection of INKV antibodies in humans, and then we studied a panel of 1,292 sera in patients with a febrile illness in Finland. We found four acute (immunoglobulin M [IgM] positive) INKV infections and an IgG seroprevalence of 51.3%. The data indicate that the infection has become more common than it was in the 1960s, especially in southern Finland. Two distinct IgG IFA fluorescence patterns were observed: a granular pattern in sera from patients with acute INKV infection and a diffuse pattern in those with long-standing immunity. Further analysis with a panel of INKV-positive sera (n = 18; verified by neutralization assay) of protein-specific responses, using immunoprecipitation and IFA based on baculovirus-expressed INK N, Gn, and Gc proteins, demonstrated a strong IgG response predominantly towards N protein in the acute phase. In contrast, in patients with long-standing immunity, the Gc response was more prominent and the N response was weaker. In conclusion, a diagnostic IgG IFA pattern distinguishing between acute infection and long-standing immunity was observed. N protein seems to be the optimal antigen for the serodiagnosis of acute infection, and the Gc protein could be appropriate for the serosurveillance of INKV.

Published ahead of print on 17 October 2007.